Russia agreed to transfer Sputnik V production technologies to Mexico
https://ria.ru/20211014/koronavirus-1754652116.html
Russia agreed to transfer Sputnik V production technologies to Mexico
Russia agreed to transfer Sputnik V production technologies to Mexico – RIA Novosti, 10/14/2021
Russia agreed to transfer Sputnik V production technologies to Mexico
The Mexican laboratory of biological agents and reagents Birmex signed an agreement with the Russian Direct Investment Fund (RDIF) on technology transfer … RIA Novosti, 10/14/2021
2021-10-14T21: 58
2021-10-14T21: 58
2021-10-14T22: 24
spread of coronavirus
Mexico
Moscow
health – society
health
Russian direct investment fund
coronavirus covid-19
coronavirus in Russia
/ html / head / meta[@name=”og:title”]/@content
/ html / head / meta[@name=”og:description”]/@content
https://cdnn21.img.ria.ru/images/07e4/0c/16/1590368712_0:68:2524:1488_1920x0_80_0_0_8b753f2baa293a2f1f275b0b23080d45.jpg
MEXICO, October 14 – RIA Novosti. The Mexican laboratory of biological agents and reagents Birmex has signed an agreement with the Russian Direct Investment Fund (RDIF) on the transfer of technologies for the production of the Sputnik V vaccine to Mexico, laboratory director Pedro Centeno told RIA Novosti. Mexico, – said the CEO of Birmex after signing the documents in Moscow. … According to Centeno, the new venture allows organizing the transfer of technology and information to organize a full production cycle in Mexico. The production of Sputnik V in other countries has already begun: on October 12, the Uzbek Jurabek Laboratories delivered the first batch of the produced vaccines to the domestic market. Earlier, representatives of Hungary and Argentina made a statement about their intention to obtain Sputnik V technologies this year, and the launch of Sputnik’s production in Belarus is also scheduled for this year. more than 50% of the world’s population. Sputnik V ranks second in the world in terms of the number of approvals received by government regulators. The effectiveness of the vaccine was 97.6% according to the analysis of data on 3.8 million vaccinated Russians, which is higher than the data previously published by the medical journal The Lancet (91.6%), the Russian Direct Investment Fund (RDIF) and the Gamaleya Research Center reported earlier.
https://ria.ru/20211014/sputnik-1754610879.html
Mexico
Moscow
RIA News
7 495 645-6601
FSUE MIA “Russia Today”
https: //xn--c1acbl2abdlkab1og.xn--p1ai/awards/
2021 g.
RIA News
7 495 645-6601
FSUE MIA “Russia Today”
https: //xn--c1acbl2abdlkab1og.xn--p1ai/awards/
news
ru-RU
https://ria.ru/docs/about/copyright.html
https: //xn--c1acbl2abdlkab1og.xn--p1ai/
RIA News
7 495 645-6601
FSUE MIA “Russia Today”
https: //xn--c1acbl2abdlkab1og.xn--p1ai/awards/
RIA News
7 495 645-6601
FSUE MIA “Russia Today”
https: //xn--c1acbl2abdlkab1og.xn--p1ai/awards/
RIA News
7 495 645-6601
FSUE MIA “Russia Today”
https: //xn--c1acbl2abdlkab1og.xn--p1ai/awards/
mex, moscow, health – society, health, russian direct investment fund, coronavirus covid-19, coronavirus in russia, sputnik v vaccine
Russia agreed to transfer Sputnik V production technologies to Mexico